PRPF38B and breast carcinoma: Our subsequent detection of PRPF38B in a SEREX screen of sera from patients with breast cancer and the demonstration that it is over-expressed in breast cancer tissue led us to evaluate PRPF38B expression as a prognostic and therapeutic outcome predictor in a large series of breast cancers.